BD to Invest $19 billion to Boost Domestic Production of Essential Medical Supplies

The company will also source American-made steel for all needles used in the U.S.

Large group of BD company employees standing together outside a modern industrial facility with white and teal metal roofing.
Employees standing outside of a BD facility.
BD

FRANKLIN LAKES, N.J. -- BD (Becton, Dickinson and Company), a manufacturer of essential medical consumables, today announced a new partnership with the U.S. government to expand domestic manufacturing and strengthen the supply chain resilience of essential medical consumables. 

BD plans to invest some $19 billion in the U.S. over several years, including capital, operational and supply chain investments. About $3 billion of the overall investment will go toward U.S. manufacturing expansion focused on strategic production sites across the country.

The company will also expand end-to-end U.S. production by approximately 5 billion essential medical consumables annually, raising BD's share of domestically supplied essential medical consumables to roughly 80 percent. Finally, BD will source American-made steel for all needles used in the U.S.

The agreement with the government provides relief from future tariffs imposed under Section 232 on covered BD products and inputs, subject to the final scope and implementation of any future Section 232 actions and BD's achievement of agreed milestones.

Because the final tariff rates, product scope and effective timing have not yet been determined, BD is not quantifying the financial impact of the agreement.

The company expects to provide additional information when the Section 232 tariffs are finalized.  

"This agreement reflects a shared commitment between the U.S. Government and BD to strengthening America's healthcare infrastructure, expanding U.S. manufacturing capacity and supporting reliable access to essential medical technologies," said Tom Polen, chairman, CEO and president of BD. "The administration recognizes the importance of investing in a stronger, more secure healthcare supply chain, and BD is uniquely positioned to help bring that vision to life through our scale, innovation expertise and longstanding U.S. manufacturing footprint.

BD's U.S. manufacturing network includes Columbus and Broken Bow, NE; Canaan, CT; Añasco, PR; Sandy, UT; El Paso, TX; Covington, GA; and Sumter, SC.

More in Medical